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Attitudes towards deprescribing and the influence of health literacy among older
Australians
Abstract
Aim
This study aimed to explore attitudes, beliefs and experiences regarding polypharmacy and discontinuing
medications, or deprescribing, among community living older adults aged ≥65 years, using ≥5
medications. It also aimed to investigate if health literacy capabilities influenced attitudes and beliefs
towards deprescribing. Background
Polypharmacy use is common among Australian older adults. However, little is known about their
attitudes towards polypharmacy use or towards stopping medications. Previous studies indicate that
health literacy levels tend to be lower in older adults, resulting in poor knowledge about medications.
Methods
A self-administered survey was conducted using two previously validated tools; the Patients’ Attitude
Towards Deprescribing (PATD) tool to measure attitudes towards polypharmacy use and deprescribing
and the All Aspects of Health Literacy Scale (AAHLS) to measure functional, communicative and critical
health literacy. Descriptive statistical analysis was conducted. Findings
The 137 responses showed that 80% thought all their medications were necessary and were comfortable
with the number taken. Wanting to reduce the number of medications taken was associated with
concerns about the amount taken (P<0.001), experiencing side effects (P<0.001), or believing that one or
more medications were no longer needed (P<0.000). Those who were using ten or more medications
were more likely to want to reduce the number taken (P=0.019). Most (88%) respondents would be willing
to stop medication/s in the context of receiving this advice from their doctor. Willingness to consider
stopping correlated with higher scores on the critical health literacy subscale (P<0.021) and overall
AAHLS score (P<0.009). Those with higher scores on the overall AAHLS measure were more likely to
report that they understood why their medications were prescribed (P<0.000) and were more likely to
participate in decision-making (P=0.027). Opportunities to proactively consider deprescribing may be
missed, as one third of the respondents could not recall a recent review of their medications.
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Aim: This study aimed to explore attitudes, beliefs and experiences regarding polypharmacy
and discontinuing medications, or deprescribing, among community living older adults aged
≥65 years, using ≥5 medications. It also aimed to investigate if health literacy capabilities
influenced attitudes and beliefs towards deprescribing. Background: Polypharmacy use is
common among Australian older adults. However, little is known about their attitudes
towards polypharmacy use or towards stopping medications. Previous studies indicate that
health literacy levels tend to be lower in older adults, resulting in poor knowledge about
medications. Methods: A self-administered survey was conducted using two previously
validated tools; the Patients’ Attitude Towards Deprescribing (PATD) tool to measure
attitudes towards polypharmacy use and deprescribing and the All Aspects of Health Literacy
Scale (AAHLS) to measure functional, communicative and critical health literacy. Descriptive
statistical analysis was conducted. Findings: The 137 responses showed that 80% thought all
their medications were necessary and were comfortable with the number taken. Wanting to
reduce the number of medications taken was associated with concerns about the amount
taken (P < 0.001), experiencing side effects (P < 0.001), or believing that one or more
medications were no longer needed (P < 0.000). Those who were using ten or more
medications were more likely to want to reduce the number taken (P = 0.019). Most (88%)
respondents would be willing to stop medication/s in the context of receiving this advice from
their doctor. Willingness to consider stopping correlated with higher scores on the critical
health literacy subscale (P < 0.021) and overall AAHLS score (P < 0.009). Those with higher
scores on the overall AAHLS measure were more likely to report that they understood why
their medications were prescribed (P < 0.000) and were more likely to participate in decisionmaking (P = 0.027). Opportunities to proactively consider deprescribing may be missed, as
one third of the respondents could not recall a recent review of their medications.

Introduction

©The Author(s) 2019. This is an Open Access
article, distributed under the terms of the
Creative Commons Attribution licence (http://
creativecommons.org/licenses/by/4.0/), which
permits unrestricted re-use, distribution, and
reproduction in any medium, provided the
original work is properly cited.

Worldwide, the number of older adults is increasing rapidly and in high income countries
between 20 and 30% of the population are aged over 60 (World Health Organization, 2015).
While the health of older adults varies, the prevalence of multiple morbidities among them is
markedly higher (Marengoni et al., 2011), which in-part contributes to increasing polypharmacy (Hovstadius et al., 2010; Guthrie et al., 2015; Kantor et al., 2015). In older adults,
polypharmacy, commonly defined as taking five or more concurrent medications (Gnjidic,
2012) is potentially problematic, because it can be associated with an increased risk of falls
(Niikawa et al., 2017), mortality (Jyrkkä et al., 2009b) and hospitalisations (Reason et al.,
2012). Deprescribing, a strategy designed to reduce inappropriate polypharmacy, involves
discontinuing medications that are no longer required or are potentially harmful (Page et al.,
2018). Non-randomised trials of deprescribing in older adults using polypharmacy have
shown a sustained decrease in the number of medications taken and an improvement in
clinical outcomes (Page et al., 2016; Garfinkel, 2018).
Deprescribing, however, may not be considered a routine part of the prescribing continuum
(Bain et al., 2008) because of health system, prescriber and patient related barriers (Gillespie
et al., 2018). Patient-related barriers include; beliefs about the necessity of medications, fear of
symptom return or withdrawal symptoms (Reeve et al., 2013b). Other patient-related barriers
may include an inability to comprehend health information or to communicate their preferences
with their doctors (Holmes and Todd, 2017). Older age has been associated with low health
literacy (Baker et al., 2000; Kutner et al., 2006; Wolf et al., 2010; Bostock and Steptoe, 2012;
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Geboers et al., 2016) which contributes to poor knowledge
and understanding about medications (Mosher et al., 2012) and
polypharmacy (Huxhagen, 2018).
Worldwide, studies indicate that most patients are hypothetically willing to stop one or more of their regular medications
(71–93%), if their doctor thought it was possible (Galazzi et al.,
2016; Ng et al., 2017; Sirois et al., 2017; Tegegn et al., 2018). These
findings concur with three Australian studies which found that
patients’ willingness to consider deprescribing ranged from
79–92% (Reeve et al., 2013c; Qi et al., 2015; Kalogianis et al.,
2016). These studies investigated interest towards deprescribing
for older aged care facility residents (Kalogianis et al., 2016), older
hospital inpatients (Qi et al., 2015) and adults (≥18 years) with
multiple chronic morbidities (Reeve et al., 2013c). They did not,
however, investigate the attitudes towards deprescribing of
autonomous community living older adults, who make up the
majority of the older Australian population (Australian Institute
of Health and Welfare, 2017), and who are likely to use polypharmacy (Morgan et al., 2012).
This study aimed to explore attitudes, beliefs and experiences
regarding polypharmacy and deprescribing among communityliving older adults, taking five or more medications. It also aimed
to investigate if health literacy capabilities influenced older adults’
attitudes and beliefs towards deprescribing.

Methods
Study population and recruitment
Independent community living older adults, aged 65 years or
older, taking five or more prescribed medications, were invited to
complete an anonymous survey between October 2015 and
November 2016. Two different approaches were used to recruit
participants. The first involved a purposive sample of 23 community pharmacies, located in regional Australia, which were
invited to assist with distributing surveys to eligible participants.
Eleven pharmacies volunteered to assist and were provided with a
total of 330 surveys for distribution. However, it is not known
whether all the surveys were distributed. The second approach
involved 415 surveys being distributed by the lead author to eligible participants attending older adult community groups located within the same regional area. Only those who were literate in
English were able to complete the survey, which they returned via
reply paid envelopes.
Survey
The 42 item survey included: 15 demographic items; 13 Patients’
Attitude Towards Deprescribing (PATD) questionnaire items
(Reeve et al., 2013a); 10 All Aspects of Health Literacy Scale
(AAHLS) items (Chinn and McCarthy, 2013); three items from
the Canadian Survey of Experiences with Primary Health Care
(Statistics Canada, 2009); and one additional item to measure the
actual impact of cost. The original validated PATD questionnaire
was chosen because it measures the medication users’ attitudes
towards deprescribing and polypharmacy (Reeve et al., 2013a).
However, two of the PATD questions were removed because they
focus on attitudes towards pharmacist involvement and follow-up
which was not the focus of this study. The AAHLS was chosen
because it attempts to assess multiple dimensions of health literacy; functional communicative and critical health literacy skills
(Chinn and McCarthy, 2013). These three domains are based on
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Nutbeam’s health literacy model which acknowledges the
importance of a wider set of cognitive and social skills to enable
individuals to interact with and interpret the health system and
health information (Nutbeam, 2000). The functional health literacy items in AAHLS measure reading and writing skills and the
ability to access support networks when reading and/or writing
skills are limited. The communicative health literacy items measure information gathering and interactive skills required to
consult with health practitioners. Critical health literacy items
measure respondents’ information appraisal skills in assessing the
relevance, reliability, credibility and validity of health information
(Chinn, 2011; Chinn and McCarthy, 2013). For this study, three
of the AAHLS questions which address health literacy capabilities
at the level of community engagement were not included.
Statistical analysis
Descriptive statistics were used to analyse the data using SPSS
version 24 (IMB Corp, 2016). Frequencies and percentages were
reported for responses to the PATD questions 1–10 and the
additional questions 11–17. For the AAHLS potential scores for
each individual item ranged from 1 (lowest) to 3 (highest) (Chinn
and McCarthy, 2013). Items that were negatively worded were
reverse coded. Responses to each item were summed and a
summed score was calculated for each subscale (potential functional scores 3–9; communicative scores 3–9; critical scores 4–12)
and for the AAHLS as a whole (potential scores 10–30). Based on
evidence (Chinn and McCarthy, 2013), no cut-off for adequate
health literacy was determined using this scale. However, for the
purposes of analysis, lower summed scores (for each subscale and
the AAHLS as a whole) were assumed to indicate lower health
literacy capabilities. For analysis purposes, age was grouped into
younger (≤76 years) or older (77 + ); Socio-Economic Index For
Areas (SEIFA) was divided into high or low (Australian Bureau of
Statistics, 2013); and the number of medications were grouped
into polypharmacy (5–9 medications) and excessive polypharmacy (≥10 medications) (Jyrkkä et al., 2009a).
Spearman’s correlations were used to test for any associations
between PATD items. Mann–Whitney U tests or Kruskal–Wallis
H tests were used to investigate differences between groups of
dichotomous or multinomial non-parametric ordinal items. Significant associations were assumed if the P value was ≤0.05.
Results
A total of 187 respondents returned the survey, suggesting a
25.1% response rate if all surveys were distributed. This response
rate compares well with evidence that 27.9% is an average
response rate for surveys (Guo et al., 2016). Fifty survey responses
were excluded from the final analysis because respondents were
less than 65 years old, gave no indication of their age and/or
number of prescribed medications, or were taking fewer than five
prescription medications. Data quality was high. For the first 10
items of the PATD questions the median percentage of missing
responses per item was 1.0% (range 0.0–4.4%) and for the
AAHLS items the median percentage missing was 1.5% (range
0.7–5.1%).
Table 1 presents the demographic characteristics of the 137
respondents included in the analysis. The median age of
respondents was 76 years which included more females (60.5%).
Respondents were prescribed a median of seven medications and
were living with a median of three self-reported diseases. Over
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Table 1. (Continued )

Table 1. Respondent characteristics
Characteristic
Age (years), median (IQR)

Respondent (n = 137)
76 (73–83)

Gender
Female

83 (60.5)

Male

52 (38.0)

Missing

2 (1.5)

Number of medications (median) (IQR)

7 ( 5–9)

Number of illness (self-report) (median) (IQR)

3 (2–4)
Number of respondents (%)

Self-reported health status
Very good or excellent

30 (21.9)

Good

61 (44.5)

Fair or poor

42 (30.7)

Missing

4 (2.9)

Self-reported QoL
Very good or excellent

54 (39.4)

Good

51 (37.2)

Fair or poor

29 (21.2)

Missing

3 (2.2)

SEIFA decile
High

67 (48.9)

Low

69 (50.4)

Missing

1 (0.7)

Location (ASGC)
City
Inner regional
Missing

109 (79.6)
27 (19.7)
1 (0.7)

Highest education completed
Primary or less

3 (2.2)

High school (year 10 or below)

48 (35.0)

High school (year 12 complete)

13 (9.5)

TAFE/Trade/Apprenticeship

41 (29.9)

University or higher

29 (21.2)

Missing

3 (2.2)

Country of birth
Australia
UK/Ireland

100 (73)
25 (18.2)

Europe

5 (3.6)

N.Z.

3 (2.2)

Characteristic

Respondent (n = 137)

Other

1 (0.7)

missing

3 (2.2)

IQR = interquartile range; QoL = quality of life; SEIFA = Socio-Economic Index for Areas;
ASGC = Australian Statistical Geography Standard.

two-thirds (66.4%) reported good to excellent health and most
(76.6%) reported experiencing a good to excellent quality of life
(QoL). The majority of respondents were either born in Australia
(73%) or emigrated from English speaking countries (20.4%) and
more than half (51.1%) had completed either an Apprenticeship/
Trade or university qualification. Respondents resided in locations which were almost evenly distributed between high (48.9%)
and low (50.4%) SEIFA, which is a measure of the level of socioeconomic advantage and disadvantage of an area, relative to other
areas (Australian Bureau of Statistics, 2013). Only one in five lived
in inner regional locations, as defined by the Australian Statistical
Geography Standard with the remainder (79.6%) living in a major
city. No relevant significant associations were found between
individual respondent characteristics (listed in Table 1) and
willingness to stop medications (data not shown).
Responses to the PATD questionnaire
The PATD responses (Figure 1) show that almost half of the
respondents strongly agreed/agreed (49%) that they were taking
a large number of medications. However, the majority of them
were comfortable with the number of medications they were
taking (80%) and believed they were necessary (80%). Nearly all
respondents (91%) believed that they understood why they were
taking their medications and most of them (74%) agreed that
they would accept taking more medications for their health
conditions.
Most respondents were unsure or disagreed (82%) that they
were taking medications that they did not need and yet 88%
agreed that they would be willing to stop one or more of their
medications, if their doctor thought it possible. Importantly, over
half (56%) agreed that they would like to reduce the number of
medications they were taking. Approximately, one-fifth of the
respondents (22%) agreed that their medications were giving
them side effects and a similar proportion (20%) agreed that costs
would impact on their willingness to stop one or more medications (Figure 1).
The results in Table 2 suggest that less than half of the
respondents (45.3%) reported having actually stopped a medication in the past. Perceptions of what constituted ‘a lot’ of medications varied, with almost one third (32.1%) considering 5–9
medications was ‘a lot’ and a greater proportion (41.6%) considering that 10–14 was ‘a lot’. The majority of respondents
(62.7%) indicated that that they would be comfortable taking
≤ eight medications per day.
The results of Table 2 also highlight that the majority of
respondents (93.4%) did not find paying for medications a
financial burden and most (65.7%) recalled their doctor checking
their medication in the past 12 months. Just over half (53.3%)
believed that their doctors often allowed for enough time to
discuss their feelings, fears and concerns about their medications
and only 15.3% believed that their doctor rarely involved them in
decisions about their medication(s).
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Figure 1. Patients’ Attitude Towards Deprescribing responses:questions 1–10.

Association between number of medications taken and PATD
items
Analysis was undertaken to investigate if there were any correlations between the number of medications taken (5–9 or ≥10 or
more) and responses to the first ten PATD items (see Table 3).
Those who were using ten or more were significantly more likely
to want to reduce the number of medications taken, felt that they
were taking a large number of medications, and that they were
taking medications they no longer needed. They were also significantly more likely to feel that one or more of their medications
were giving them side effects. In contrast, respondents in the
group taking five to nine medications were significantly more
likely to be comfortable with the number of medications they
were taking, more likely to believe that all their medications were
necessary and more likely to understand why they were taking
their medications. While it was not statistically significant, all the
respondents taking ten or more medications were willing to
consider stopping one or more of their regular medications.

Relationship between PATD items and the willingness to stop
or reduce medications.
The current study investigated if there was an association between
respondents’ willingness to stop one or more of their medications
or their desire to reduce the number of their medication(s) and
the first 10 PATD items (Table 4). There was a positive correlation between responses to wanting to reduce their medications,
feeling that they were taking a large number of medications,
taking a medication that is no longer needed and experiencing
side effects. Negative correlations were noted between wanting to
reduce medications and being comfortable with the number taken
and believing that all current medications were necessary. When
considering willingness to stop medication/s, the results highlight
that there was a positive correlation between willingness to stop

and a desire to reduce the number taken and also accepting more
medications to manage health conditions. It should be noted that
most correlations were weak with only one moderate correlation
(r 2 0.442) between wanting to reduce the number of medications
and taking one or more medications that may no longer be
needed (Table 4).
Responses to the AAHLS questionnaire
Most respondents demonstrated higher summed scores on both
the functional (Figure 2a) and communicative subscales
(Figure 2b), whereas summed critical health literacy subscale
scores (Figure 2c) were more variable. Overall summed scores for
the AAHLS (Figure 2d), as a whole, also indicated variability
among respondents.
Relationship between PATD items and summed health
literacy scores
Table 5 highlights the significant correlations between health
literacy scores and PATD items. Significant correlations were
weak to moderate. There was a positive correlation between
responses to having a good understanding of the reasons medications had been prescribed and each of the subscales of health
literacy (functional, communicative, critical) and overall health
literacy score. Further positive correlations between functional
health literacy scores and being comfortable with the number of
medications taken and believing that all medications were
necessary were noted. In contrast, there was a negative correlation
between both functional and communicative health literacy scores
and feeling that that one or more medication/s may no longer be
needed. Communicative health literacy scores were positively
correlated with a willingness to accept taking more medications.
In addition, there was a positive correlation between willingness
to stop one or more medications and critical health literacy scores

Downloaded from https://www.cambridge.org/core. University of Wollongong, on 16 Jul 2019 at 23:14:38, subject to the Cambridge Core terms of use, available at
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S1463423618000919

Primary Health Care Research & Development

5

Table 2. Patients’ Attitude Towards Deprescribing (PATD) responses (questions
11–13) and additional questions
Answer

N (%)

PATD responses (questions 11–13)

Table 2. (Continued )
Answer

Does your doctor allow you enough time to discuss your feelings, fears
or concerns about new medicines or medicines you may have been
taking for some time?

Have you ever tried to stop a regular medication
Yes

62 (45.3)

No

74 (54.0)

Missing

1 (0.7)

How many tablets/capsules taken each day would you consider to be
a lot?
5–9

44 (32.1)

10–14

57 (41.6)

15–19

21 (15.3)

> 20
Missing

10 (7.3)
5 (3.6)

What is the maximum number of tablets/capsules that you would be
comfortable taking in one day? (Pictorial response options)
4

35 (25.5)

8

51 (37.2)

12

31 (22.6)

16

5 (3.6)

20

2 (1.5)

24

2 (1.5)

Missing

11 (8.0)

Additional questions 14–17
In the past 12 months, have you delayed or not bought one or several
medications because you needed to spend your money on other items?
Yes

4 (3.0)

No

128 (93.4)

Missing

5 (3.6)

In the past 12 months, has your doctor taken time during a consultation
to check all the different medications you are using, including
medication prescribed by other medical doctors?
Yes

90 (65.7)

No

42 (30.7)

Missing

5 (3.6)

In the past 12 months, how often did your doctor involve you in
decisions related to your medications?
Rarely

21 (15.3)

Sometimes

41 (30.0)

Often

57 (41.6)

N/A

10 (7.3)

Missing

8 (5.8)

N (%)

Rarely

13 (9.5)

Sometimes

39 (28.5)

Often

73 (53.3)

N/A

7 (5.1)

Missing

5 (3.6)

N/A = not applicable.

and overall AHHLS scores. A further positive correlation was
noted between overall AHHLS scores and believing that all
medications were necessary (Table 5).
Relationships between the PATD questions 11–13, the additional questions and summed overall AAHLS scores were investigated. Recalling a medication review (U = 1083.50, P = 0.0031),
believing there was enough time in consultations (rs = 196,
P = 0.031) and being involved in medication decision making (rs
= 198, P = 0.027) were associated with higher overall summed
health literacy scores. There were no significant associations
found with other items.
Individual characteristics and overall summed health literacy
score.
Summed overall AAHLS scores were investigated to identify if
there were any associations between health literacy capabilities
and individual respondent characteristics. Respondents with
lower overall AAHLS scores were significantly more likely to be in
the group using 10 or more medications (U = 921.50, P = 0.003)
and were significantly more likely to self-report a poorer QoL (χ 2
(2) = 7.241, P < 0.027) and a poorer health status (χ 2 (2) = 6.698,
P <0.035). No other significant associations were found between
overall AAHLS scores and respondent characteristics, such as
gender, number of self-reported illnesses, location of residence,
SEIFA decile and completed education levels.
Discussion
The current study findings support previous evidence that most
older adults are willing to consider stopping one or more of their
medications if deemed appropriate by their doctor (Qi et al.,
2015; Galazzi et al., 2016; Kalogianis et al., 2016; Sirois et al.,
2017; Tegegn et al., 2018). These findings also concur with
qualitative evidence indicating that older adults respect their
doctor’s suggestions about deprescribing (Linsky et al., 2015a;
Clyne et al., 2017), especially if they have established a longterm relationship and trust their doctor (Moen et al., 2009;
Clyne et al., 2017). Potentially, trust and confidence in their
doctors’ decisions may also explain why most respondents felt
comfortable with taking their medications and thought they
were all necessary.
It may be that specific cut-points to identify polypharmacy
have limited usefulness in clinical practice (Cadogan et al., 2016).
It is apparent that many older adults have a pragmatic approach
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Table 3. Differences in responses to Patients’ Attitude Towards Deprescribing (PATD) items and polypharmacy status
5–9 medications
N (%) agreed/strongly
agreedb

≥ 10 medications
N (%) agreed/strongly
agreedb

P-value

I feel that I am taking a large number of medications

46 (44.2)

21 (77.8)

P = 0.005a

I am comfortable with the number of medications that I am taking

90 (84.1)

19 (63.3)

P = 0.015a

I believe that all my medications are necessary

89 (83.2)

20 (66.7)

P = 0.042a

If my doctor said it was possible, I would be willing to stop one or more of my regular
medications

91 (85.0)

30 (100.0)

P = 0.062

I would like to reduce the number of medications that I am taking

56 (52.3)

21 (72.4)

P = 0.019a

I feel that I may be taking one or more medications that I no longer need

13 (12.1)

11 (37.9)

P = 0.008a

I would accept taking more medications for my health conditions

78 (73.6)

23 (76.7)

P = 0.350

101 (95.3)

23 (76.7)

P = 0.003a

Having to pay for fewer medications would play a role in my willingness to stop one or more
of my medications

22 (21.0)

5 (17.2)

P = 0.986

I believe one or more of my medications is giving me side effects

19 (17.9)

11 (36.7)

P = 0.042a

PATD items

I have a good understanding of the reasons I was prescribed each of my medications

a

Mann–Whitney is significant at the P < 0.05 level.
Proportions are included to assist with the interpretation of the results.

b

Table 4. Associations between Patients’ Attitude Towards Deprescribing (PATD) responses

PATD items

If my doctor said it was possible, I would be willing to I would like to reduce the number of
stop one or more of my regular medications
medications that I am taking

I feel that I am taking a large number of medications

rs0.065, P < 0.462

rs 0.299, P < 0.001*

I am comfortable with the number of medications that
I am taking

rs −0.004, P < 0.966

rs −0.335, P < 0.000*

I believe that all my medications are necessary

rs −0.003, P < 0.977

rs −0.256, P < 0.003*

If my doctor said it was possible, I would be willing to
stop one or more of my regular medications

–

rs0.194*, P < 0.024

I would like to reduce the number of medications that I am
taking

rs0.309, P < 0.000*

–

I feel that I may be taking one or more medications that
I no longer need

rs0.094, P < 0.277

rs0.442, P < 0.000*

I would accept taking more medications for my health
conditions

rs0.194, P < 0.024*

rS −0.154, P < 0.075

I have a good understanding of the reasons I was
prescribed each of my medications

rs0.133, P < 0.123

rs − 0.076, P < 0.378

Having to pay for fewer medications would play a role in my rs −0.069, P < 0.429
willingness to stop one or more of my medications
I believe one or more of my medications is giving me side
effects

rs −0.046, P < 0.595

rs0.153, P < 0.077
rs0.288, P < 0.001*

r 2 Spearman correlation
Interpretation of r values (Dancey and Reidy, 2007).
Strength of relationship: ±0.1 to ±0.3 weak, ±0.4 to ±0.6 moderate, ±0.7 to ± 0.9, strong, ±1 perfect.
*Spearman’s correlation is significant at the P < 0.05 level.

to polypharmacy, in that most would consider taking more
medications if their health required it and in practice, GPs also do
not adhere to a fixed definition of polypharmacy (Moen et al.,
2010; Linsky et al., 2015b). The emphasis should be on managing
the ongoing appropriateness of medications for each individual,
taking into account their preferences (Duerden and Payne, 2015)

and considering the overall burden of polypharmacy use for the
patient (Krska et al., 2017).
The burden of polypharmacy may be influential in wanting to
stop medications. Our finding that respondents taking ten or
more medications were more likely than those taking 5–9 to want
to reduce the number of medications taken is novel, contradicting
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Figure 2. Distributions of health literacy scores. (a) Functional health literacy scores; (b) Communicative health literacy scores; (c) Critical health literacy scores; (d) Overall
health literacy scores.

previous studies which found no significant relationship between
the number taken and a desire to reduce (Galazzi et al., 2016;
Kalogianis et al., 2016). This suggests that those taking fewer than
ten medications may not think to discuss stopping any with their
doctor because, as the findings show, they are comfortable with
the number they are taking. In addition, some respondents were
more likely to consider reducing the number of their medications,
including those who were not comfortable with the number they
were taking, believed they were taking medications that they no
longer needed, or if they were experiencing side effects.
In the current study, one-fifth of the respondents indicated
that reducing costs was a factor that would influence their willingness to consider stopping medication/s. This finding was
unexpected as few respondents indicated that purchasing their
medications was creating a financial burden. Furthermore, costs
for prescription medications are subsidised by the Australian
government, especially for older adults, many of whom would
qualify for government healthcare subsidies. However, controlling
costs may be an important issue in countries where prescription

costs are not subsidised to the same extent (see The Commonwealth Fund 2017). For instance, a US qualitative study found
that older adults, including those with health insurance, reported
sometimes stopping their medication/s to help reduce costs
(Elliott et al., 2007). As polypharmacy rates continue to increase,
costs may become a greater burden. However, cost considerations
should not be the basis on which deprescribing decisions
are made.
Significant correlations between individual characteristics and
health literacy levels were noted. Lower overall health literacy
scores were associated with self-reports of poorer QoL and poorer
overall health. These findings are consistent with previous
research which found low health literacy levels to be an independent indicator for low self-rated health status among older
adults (Bennett et al., 2009) and poorer QoL (Panagioti et al.,
2018). It is not possible to determine from our results the
direction of this relationship; poorer QoL and lower overall health
may be contributing to lower health literacy scores. Definitions
which regard health literacy as a dynamic skill that is changeable
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Table 5. Relationship between Patients’ Attitude Towards Deprescribing (PATD) and summed health literacy scores
Summed health literacy scores
PATD items

Functional

Communicative

Critical

Overall

I feel that I am taking a large number of medications

rs = − 0.064,
P < 0.479

rs = − 0.030,
P < 0.735

rs = 0.083,
P < 0.345

rs = 0.020,
P < 0.830

I am comfortable with the number of medications that I am taking

rs = 0.206,
P < 0.019*

rs = 0.037,
P < 0.671

rs = −0.010,
P < 0.904

rs = 0.095,
P < 0.286

I believe that all my medications are necessary

rs = 0.268,
P < 0.002*

rs = 0.152,
P < 0.078

rs = 0.036,
P < 0.679

rs = 0.182,
P < 0.039*

If my doctor said it was possible, I would be willing to stop one or more of my regular
medications

rs = 0.038,
P < 0.673

rs = 0.164,
P < 0.057

rs = 0.198,
P < 0.021*

rs = 0.229,
P < 0.009*

I would like to reduce the number of medications that I am taking

rs = −0.059,
p < 0.508

rs = −0.009,
P < 0.916

rs = 0.145,
P < 0.094

rs = 0.093,
P < 0.294

I feel that I may be taking one or more medications that I no longer need

rs = − 0.244,
P < 0.005*

rs = −0.266,
P < 0.002*

rs = −0.003,
P < 0.970

rs = −0.156,
P < 0.078

I would accept taking more medications for my health conditions

rs = 0.120,
P < 0.176

rs = 0.316,
P < 0.000*

rs = −0.156,
P < 0.070

rs = − 0.007,
P < 0.936

I have a good understanding of the reasons I was prescribed each of my medications

rs = 0.336,
P < 0.000*

rs = 0.203,
P < 0.019*

rs = 0.170,
P < 0.048*

rs = 0.324,
P < 0.000*

Having to pay for fewer medications would play a role in my willingness to stop one or
more of my medications

rs = −0.118,
P < 0.186

rs = −0.146,
P < 0.094

rs = − 0.003,
P < 0.973

rs = −0.069,
P < 0.443

I believe one or more of my medications is giving me side effects

rs = −0.031,
P < 0.731

rs = −0.130,
P < 0.134

rs = − 0.050,
P < 0.561

rs = −0.071,
P < 0.426

Spearman correlation.
Interpretation of r values (Dancey and Reidy, 2007).
Strength of relationship: ±0.1 to ±0.3 weak, ±0.4 to ±0.6 moderate, ±0.7 to ±0.9, strong, ±1 perfect.
*Correlation is significant at the p < 0.05 level.

through the life course would support this interpretation (Squiers
et al., 2012). As no significant correlations were noted between
socio economic status and education in the present study, these
factors do not appear to influence the health literacy scores in this
sample. These findings are in contrast to other studies, which
found that education status and indicators of socio economic
position were associated with health literacy level among older
adults (Bostock and Steptoe, 2012; Wolf et al., 2010).
Respondents scored highly on the functional health literacy
scale which contradicted previous studies conducted among older
adults in the United States using the Short Test of Functional
Health Literacy in Adults (S-TOFLA) (Baker et al., 2000; Wolf
et al., 2010) and in England using a brief four item scale (Bostock
and Steptoe, 2012). Both these studies measure comprehension of
text. Whereas the functional health literacy subscale in the
AAHLS asks how often help is required to read health information or to fill in forms. Perhaps this difference explains the higher
functional health literacy scores seen in the current study. To our
knowledge, the AAHLS has not been used in another older adult
population.
Despite the possible differences in functional health literacy
measurement, it remains well known that functional health literacy is fundamental to being able to access and understand
written medication information, such as prescription labels or
Patient Information Leaflets (Wali et al., 2016). This was reflected
in the current study with higher functional health literacy scores
positively correlating with reporting a good understanding of the
reasons for each medication and being less likely to report taking

a medication that was perceived to be no longer needed. These
findings highlight that written medicines information, given as a
part of any prescribing/deprescribing process, should keep in
mind the functional literacy needs of older adults (Mullen et al.,
2018).
Most health literacy research assesses patients’ interactions
with written material, even though verbal communication
regarding medication information is the preferred option for
many (Hamrosi et al., 2014). Higher communicative health literacy scores among the respondents were associated with having a
good understanding of prescribed medications and being willing
to accept more medications to manage health problems. In contrast, lower scores on this subscale were associated with taking a
medication that was perceived to be no longer needed. These
results support the evidence that actively involving patients in
verbal communications about their medications is important to
facilitate a patient centred approach (Street, 2017) and is key to
understanding patients’ preferences and expectations regarding
the appropriateness of their medications (Reeve et al., 2014).
The critical health literacy results found in the present study
are difficult to interpret, which may in part be due to problems in
defining and measuring the concept of critical health literacy
(Chinn, 2011; Chinn and McCarthy, 2013). Nutbeam (2000) and
Ishikawa et al. (2008) define critical health literacy as a distinct
skill which implies measurability. However, others such as
Rubinelli et al. (2009) define it as a capacity which would preclude
objective measurement. The critical health literacy items in the
AAHLS tool were based on Ishikawa’s scale (Ishikawa et al., 2008)

Downloaded from https://www.cambridge.org/core. University of Wollongong, on 16 Jul 2019 at 23:14:38, subject to the Cambridge Core terms of use, available at
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S1463423618000919

Primary Health Care Research & Development

and were designed as a screening tool (Chinn and McCarthy,
2013). As such, the results measure the extent to which respondents engage in critical appraisal of information and do not give
any further insight into how, or indeed if, individuals apply this
knowledge to make sense of decisions about their health. How
older adults might use or apply critical health literacy skills when
considering stopping medications therefore remains unknown
and requires further research.
It is notable that higher overall AAHLS scores were positively
correlated with understanding the reasons for medications being
prescribed, participating in the decision making process and
recalling a medication review. All of these factors are likely to be
supportive of older adults’ engaging with their health care provider to discuss deprescribing as a possible medication management strategy. Earlier qualitative studies conducted with GP
participants suggested that older adults had a poor understanding
of their medications due to old age or a lack of education
(Schuling et al., 2012; Linsky et al., 2015b). However, the current
study results indicate that older adults hold a different opinion of
their capabilities and this has implications for practice, supporting
the current emphasis on incorporating shared decision making
into the deprescribing processes (Reeve et al., 2014; Jansen et al.,
2016). However, over 30% of the respondents perceived that there
was a lack of time during consultations, that they were not
included in the decision-making process and/or could not recall a
medication review. These findings suggest that opportunities
remain to improve engagement with older adults, restructuring
appointment times to allow for discussion about medications
concerns, offering regular structured medication reviews and
inviting older adults to participate, if they so choose, in decisionmaking processes regarding their medications.

Limitations
It is important to acknowledge, that the sample size for this study
was limited, although comparable to other similar studies (Reeve
et al., 2013c; Ng et al., 2017; Sirois et al., 2017). Also, respondents
were drawn from one region in Australia which suggests the
results may not be generalisable. It is possible, that the older
adults who chose to respond to the survey already held strong
opinions about the use of multiple medications and this may have
biased the findings. Furthermore, as this survey was self-administered, older adults who had low literacy or were from nonEnglish speaking backgrounds were not likely to participate. This
may have contributed to the high health literacy scores, particularly on the functional health literacy subscale. In addition, the
majority of the surveys were distributed to community groups,
which means that older adults who were active community
members may be over represented in the sample. This may also
mean that the views of frailer and socially isolated older adults
were not included in the responses. Similarly, the views of older
adults from outer regional or remote areas of Australia may not
be represented.

Conclusions
Older adults who are using polypharmacy are generally comfortable with their medications and experience few concerns. However, they may express an interest in stopping one or more of
their medications in order to reduce the number they are taking,
especially those who are using ten or more. Costs, experiencing
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side effects, or believing that medication/s may be unnecessary
may result in a desire to reduce the number of medications taken.
Higher health literacy scores were associated with key aspects
such as involvement in decision making, knowledge of medications and willingness to stop. Appropriate written and verbal
communications about medications are therefore important to
allow all older adults to understand and access the information
they require to participate in medication management decisions.
The ongoing appropriateness of medications may not be regularly
assessed for all older patients, suggesting missed opportunities to
discuss and plan deprescribing proactively.
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